Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Refractive Surgery/Vision Correction > Which is a better preventive pain regimen after photorefractive keratectomy: oral or topical NSAIDs?
  • Refractive Surgery/Vision Correction

Which is a better preventive pain regimen after photorefractive keratectomy: oral or topical NSAIDs?

Topical nonsteroidal anti-inflammatory drugs (NSAIDs) are better at reducing postoperative pain in patients after photorefractive keratectomy (PRK) than oral NSAIDs.

Ophthalmology 360

Topical nonsteroidal anti-inflammatory drugs (NSAIDs) are better at reducing postoperative pain in patients after photorefractive keratectomy (PRK) than oral NSAIDs.

In this prospective, randomized, longitudinal survey 157 patients were randomized to receive topical ketorolac 0.4% every 12 hours or oral naproxen sodium 220 mg every 12 hours for 72 hours following PRK before completing a survey on postoperative PRK pain. In patients receiving oral NSAIDs, the peak pain scores were significantly higher than those receiving topical NSAIDs. Pain scores 24 to 48 hours after PRK were significant higher in the oral NSAID group than the topical group. Pain scores were the highest 24–72 hours after surgery in all patients.

Reference

Survey of postoperative pain in photorefractive keratectomy using topical versus oral nonsteroidal anti-inflammatory drugs. Clin Ophthalmol. 2020; 2020(14):1459-1466. DOI https://doi.org/10.2147/OPTH.S255441

Share

Related Content

  • Refractive Surgery/Vision Correction

VISUMAX 800 lenticule extraction linked to high satisfaction and spectacle independence

  • Refractive Surgery/Vision Correction

First-in-human study underway for non-invasive vision correction technology

  • Refractive Surgery/Vision Correction

Tips to successfully integrate EVO ICL into office-based surgery

Dr. Ling implanting EVO ICL
  • Refractive Surgery/Vision Correction

EVO ICL plays a strategic role in my refractive business model

  • Cornea and External Disease

Who is the ideal candidate for EVO ICL?

  • Cornea and External Disease

Impact of corneal size on refractive surgery outcomes highlighted in new research

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon